Monogram Technologies to Host Investor and Analyst Tour in Austin

Monogram Technologies Inc. (NASDAQ:MGRM), an AI-driven robotics company focusing on orthopedic surgery, will host an investor and analyst day on June 20th, 2024, at its headquarters in Austin, Texas. Attendees will experience a product demonstration of the mBôs Precision Robotic Surgical System and mVision technologies.

CEO Ben Sexson, along with key members of the management team, will offer insights into the company's advancements in patient-optimized orthopedic implants, combining 3D printing, machine vision, AI, and next-gen robotics. The event aims to enhance transparency and engage a wider audience.

Verification and Validation testing of the mBôs TKA System is expected to be largely complete by Q2 2024. Monogram plans to submit for 510(k) clearance in the latter half of 2024. A Contract Research Organization has been engaged for clinical trials outside the U.S., following feedback from the FDA.

A guided tour of the headquarters and cadaver lab will be included, where investors and analysts can see the mBôs Robotic Surgical System in action. Space is limited and registration is required.